💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for GW Pharmaceuticals Plc (GWPH)
« Back to company indexGWPH Chatter Timeline
Stock Ticker for GWPH
Most Active Tweeters for GWPH
| User | Tweets |
|---|---|
| @Unicorn_Opp | 1 |
| @Stas70699731 | 1 |
| @realmaciej | 1 |
| @DisruptiveTec11 | 1 |
Recent Tweets for GWPH
 |
@Unicorn_Opp RT @DisruptiveTec11: $LEXX can have a better mouse trap then $GWPH oil delivery vs in pill form https://t.co/Oua0N62LeK January 21st 2022, 5:01pm |
 |
@DisruptiveTec11 $LEXX can have a better mouse trap then $GWPH oil delivery vs in pill form https://t.co/Oua0N62LeK January 19th 2022, 8:01pm |
 |
@realmaciej RT @saltadogato: $ZGNX - When $GWPH launched Epidiolex it was approved in Dravet & LGS. If you gross up Fintepla's sales by 5x it actually… January 19th 2022, 7:01am |
 |
@Stas70699731 RT @Unicorn_Opp: $LEXX may provide same benefits with half the dose that of $GWPH https://t.co/CpTeIrsxfA https://t.co/9oZZ9PP616 January 13th 2022, 3:01am |
 |
@Eug_Ng3 RT @HilaryKramer: I believe $GWPH remains one of the best plays on medical marijuana. While the stock has certainly had its trying times, I… January 8th 2022, 11:01am |
|
@Unicorn_Opp $LEXX may provide same benefits with half the dose that of $GWPH https://t.co/CpTeIrsxfA https://t.co/9oZZ9PP616 January 7th 2022, 1:01am |
|
@Unicorn_Opp RT @DisruptiveTec11: $LEXX can be a better mousetrap then $GWPH https://t.co/48dBeOBcqY January 6th 2022, 8:01pm |
|
@DisruptiveTec11 $LEXX can be a better mousetrap then $GWPH https://t.co/48dBeOBcqY January 4th 2022, 7:01am |
 |
@humour_humourrr Portfolio 2021 top performer % wise: $GWPH (was acquired) Worst performer: $NVCR ?? The best sell of the year:… https://t.co/MJEhkqquAy January 1st 2022, 2:01pm |
 |
@ALaughinBuckeye @stock_mj I tweeted at @grahamfarrar in Oct. how the $gwph acquisition was disappointing cuz $jazz didn’t have the… https://t.co/4AoIsMcfL4 December 19th 2021, 6:12pm |
 |
@BzCannabis RT @JavierHasse: Study Suggests Whole-Plant Medicinal Cannabis Could Be More Effective Than CBD In Epilepsy Treatment $GWPH https://t.co/Ae… December 16th 2021, 3:12pm |
 |
@JavierHasse Study Suggests Whole-Plant Medicinal Cannabis Could Be More Effective Than CBD In Epilepsy Treatment $GWPH… https://t.co/IyAd1WwLmT December 16th 2021, 3:12pm |
 |
@1anOnlyMary GW Pharma (NASDAQ: $GWPH) – Study Suggests Whole-Plant Medicinal Cannabis Could Be More Effective Than CBD In Epile… https://t.co/3IcQXON9xD December 16th 2021, 3:12am |
 |
@newsfilterio Study Suggests Whole-Plant Medicinal Cannabis Could Be More Effective Than CBD In Epilepsy Treatment $GWPH https://t.co/aSgi9ZhOzN December 15th 2021, 9:12pm |
 |
@LlcBillionaire GW Pharma (NASDAQ: $GWPH) – Study Suggests Whole-Plant Medicinal Cannabis Could Be More Effective Than CBD In Epile… https://t.co/qHtOq14A7n December 15th 2021, 9:12pm |
 |
@bthefirsttoknow First out// $GWPH: Study Suggests Whole-Plant Medicinal Cannabis Could Be More Effective Than CBD In Epilepsy Treat… https://t.co/oCUtL1mcz8 December 15th 2021, 9:12pm |
 |
@cnormanlaw @MSOElevator A few years ago $GWPH had a clinical trial on CBDv for treating certain types of seizures, but the ini… https://t.co/NRI3vQTZVo December 13th 2021, 12:12pm |
 |
@Choin62538345 $LEXX CAN BE THE NEXT $GWPH IF THEY GO ALL THE WAY ? December 8th 2021, 6:12pm |
 |
@saltadogato @chiragontwtr The IP and residual pipeline is worse at $ZGNX than $GWPH for sure. An LGS approval is not going to… https://t.co/ibRuNzqaL5 December 6th 2021, 3:12am |
 |
@chiragontwtr @saltadogato $ZGNX What about patent life ? And $GWPH wasn't all about Epidiolex. December 6th 2021, 3:12am |
|
@saltadogato $ZGNX - When $GWPH launched Epidiolex it was approved in Dravet & LGS. If you gross up Fintepla's sales by 5x it ac… https://t.co/8utcYSPFnB December 6th 2021, 3:12am |
|
@DisruptiveTec11 WHY $LEXX will surpass $GWPH a drug molecule delivery method called #Dehydratech_tm works for 2 trillion addressabl… https://t.co/MiH97XopMA December 4th 2021, 12:12pm |
|
@Unicorn_Opp @MrZackMorris Hey biatch do some dd on the next $GWPH https://t.co/GKBdVwKYcW December 3rd 2021, 4:12am |
|
@Unicorn_Opp $LEXX always a tax loss seller for mms to tKe paper from.. They see the order flow at tax loss is a tax loss.. Booyas next $GWPH November 22nd 2021, 3:11pm |
 |
@Bee20290 @MarketRebels It was $GWPH but that got sold ? .. so many to choose from so spread out across 8 different holdings now along with $MJ November 15th 2021, 11:11pm |
 |
@Benzinga RT @BzCannabis: Jazz Pharmaceuticals Reports Q3 Financial Results, Raises Full-Year Earnings Guidance | Benzinga $GWPH $JAZZ https://t.co/q… November 10th 2021, 3:11pm |
|
@BzCannabis Jazz Pharmaceuticals Reports Q3 Financial Results, Raises Full-Year Earnings Guidance | Benzinga $GWPH $JAZZ… https://t.co/xkggXNrKX0 November 10th 2021, 3:11pm |
 |
@BurritoTostada @AJ_Philly @adamfeuerstein Very true, though $GWPH had robust Method of Use patents secured, which $CMPS doesn't. C… https://t.co/emEEX5hHq4 November 9th 2021, 2:11pm |
 |
@AJ_Philly @BurritoTostada @adamfeuerstein That was the bear argument for $GWPH and didn’t work out November 9th 2021, 1:11pm |
 |
@sawbeck25 Being loaded @ACInvestorBlog has a cannabis deal with $gwph https://t.co/wi0GQJulaF https://t.co/WTOstQB1nC November 5th 2021, 7:11pm |
|
@Unicorn_Opp @gurgavin check out $LEXX news going after $GWPH 7 billion market November 1st 2021, 2:11pm |
|
@Unicorn_Opp $lexx UNDISCVERED $GWPH CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Earns Coverage for DehydraTEC… https://t.co/Hc3VUGOcyT October 30th 2021, 5:10pm |
|
@DisruptiveTec11 RT @DisruptiveTec11: $LEXX next 7 billion $GWPH Stock2Me Podcast featuring Lexaria Bioscience Corp. Chairman & CEO Chris Bunka https://t.co… October 26th 2021, 8:10pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?